viropharma-incorporated

Médias

New Data On The Challenges Of Cost Effectiveness Modeling In Paediatric Use Marketing Authorisation (PUMA) HTA Submissions Presented 15TH Annual European Congress Of The International Society For Pharmacoeconomics And Outcomes Research (ISPOR)

Médias

ViroPharma Announces The First EU Market To Launch Plenadren® (Hydrocortisone, Modified-Release Tablet) For Treatment Of Adrenal Insufficiency, The First New Treatment Innovation For Over 50 Years

Médias

Patients with Adrenal Insufficiency Report a Need for Improved Management of Their Condition

Médias

ViroPharma's Buccolam® (Midazolam, Oromucosal Solution) Licensed in Ireland for Emergency Treatment of Seizures in Children and Adolescents

Médias

ViroPharma's Buccolam®▼ (Midazolam, Oromucosal Solution) now Available in Wales for Treatment of Prolonged Acute Convulsive Seizures